Lyka Labs Ltd - LYKA LABS Share Price

Sector: Pharmaceuticals | ISIN: INE933A01014
₹ 128.85 (0.04%) icon19 Apr, 2024, 12:00:00 AM
Open
₹ 128.35
Prev. Close
₹ 128.80
Turnover(lac)
₹ 0.00
Day's High
₹ 131.00
Day's Low
₹ 125.00
52 Wk High
₹ 144.30
52 Wk Low
₹ 88.50
Book Value
₹ 27.75
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 426.36
P/E
0.00
EPS
0.00
Div. Yield
0.00

Lyka Labs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/19/2024 12:00:00 AM

    ₹ 128.85 0.05 0.04
  • Open
  • ₹ 128.35
  • Prev. Close
  • ₹ 128.8
  • Turnover(Lac.)
  • ₹ 117
  • Day's High
  • ₹ 131
  • Day's Low
  • ₹ 125
  • 52 Week's High
  • ₹ 144.3
  • 52 Week's Low
  • ₹ 88.5
  • Book Value
  • ₹ 27.75
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 426.36
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Lyka Labs Ltd Corporate Actions

08 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Jan , 2024

12:00 AM

31 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2024

12:00 AM

16 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Oct , 2023

12:00 AM

26 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Jul , 2023

12:00 AM

AGM

Announcement date: 10 Jul , 2023

View Details

26 Jul , 2023

12:00 AM

16 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Jul , 2023

12:00 AM

BookCloser

View Details

No Record Found


Lyka Labs Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Lyka Labs Ltd SHAREHOLDING SNAPSHOT
20 April , 2024 | 01:10 PM

PROMOTER - TOTAL54.81%

Indian: 54.81%

Foreign: 0%

NON-PROMOTER - TOTAL 45.19%

Institutions: 1.06%

Non-Institutions: 44.13%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Lyka Labs Ltd FINANCIALS

Lyka Labs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Lyka Labs Ltd

  • KUNAL NARENDRA GANDHI
  • Chairman & MD & CEO
  • Sandeep P Parikh
  • Non-Exec. & Independent Dir.
  • Yogesh B Shah
  • Executive Director & CFO
  • Dhara P. Shah
  • Non-Exec. & Independent Dir.
  • Kishore P Shah
  • Company Sec. & Compli. Officer
  • Babulal Jain
  • Independent Director
  • Prashant Godha
  • Director
  • Shashil Mendonsa
  • Director

Summary

Initially manufacturing formulations, Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. 83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan. Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as life-savers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders, anti-cancer products, cardio-vascular drugs and anti-inflammatory products. Lyka introduced, in India, cough lozenges containing dextromethorphan hydrobromide (DMR), favoured internationally as an effective and safe cough suppressant. Lyka has two formulations division and a bulk drugs division. It also set up additional manufacturing facilities for ointments. As part of its diversification, it has invested in Relic Finance, a company carrying on the business of finance and merchant banking.A GOI-recognised Export House, it received the Certificate of Merit for its excellent export performance in 1993-94. In the same year, it received an award from CHEMEXCIL for its outstanding performance.During 1997-98, the companys administrative office & plant at tarapur has been awarded ISO 9002 certification for its quality management... Read More


Reports by Lyka Labs Ltd


Reports by Lyka Labs Ltd

Company FAQ

No Record Found